At Neuro-Behavioral Clinical Research, we're honored to have played a part in something meaningful for the future of anxiety treatment. Definium Therapeutics has just announced positive results from the Panorama study, a Phase 3 clinical trial evaluating a new investigational treatment for Generalized Anxiety Disorder (GAD), commonly known simply as anxiety. This is the third consecutive positive Phase 3 result for this treatment, following earlier successful studies in both anxiety and...

Dr. Shishuka Malhotra, founder of Neuro-Behavioral Clinical Research, was recently featured in TIME discussing a topic she's championed since day one at NBCR: why empathy and self-awareness deserve a bigger seat at the table in modern medicine.

Neuro-Behavioral Clinical Research and Ohio Center for Hope were proud to participate in the Akron Pride Festival, which welcomed nearly 40,000 attendees. The event featured a spirited, enthusiastic crowd and provided an excellent opportunity to connect with the community while sharing information about our programs and clinical research opportunities. Our outreach efforts resulted in 45 individuals signing up to be screened for potential research study participation. Even two heavy...